Dopaminergic Pathways in Obesity-Associated Inflammation

We present an explanatory hypothesis with a model that integrate central and peripheral dopaminergic circuits in the relationship between neuroimmune and metabolic systems in obesity-associated inflammation. A perspective on the potential role of dopaminergic drugs in the context of obesity will be given.Graphical AbstractGraphical representation of central and peripheral dopaminergic pathways in obesity-associated inflammation

http://link.springer.com/10.1007/s11481-019-09863-0

Source: Journal of NeuroImmune Pharmacology - July 16, 2019 Category: Drugs & Pharmacology Source Type: research